Cargando…
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
As de novo and acquired resistance to standard first line endocrine therapies is a growing clinical challenge for estrogen receptor-positive (ER(+)) breast cancer patients, understanding the mechanisms of resistance is critical to develop novel therapeutic strategies to prevent therapeutic resistanc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134714/ https://www.ncbi.nlm.nih.gov/pubmed/30214383 http://dx.doi.org/10.1186/s12575-018-0082-9 |